Results 31 to 40 of about 79,377 (290)
Clinical Applications of the Pipeline Embolization Device [PDF]
, 2018 No abstract ...
Atallah, MD, Elias +9 more
core +2 more sources
“The unpredictable ABSORB” – very late stent thrombosis of bioresorbable vascular scaffold
Heart Views, 2019 Bioresorbable vascular scaffolds represent the next revolution in stent technology. They serve the dual purpose of antiproliferative drug delivery to vascular lumen like a drug-eluting stents (DES) as well as phased strut resorption over time leading to ...
Akshyaya Pradhan +3 more
doaj +1 more source
Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries [PDF]
, 2011 <p><b>Objective:</b> We have previously demonstrated that bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs), is effective in reducing neointimal formation in rodent models of vascular injury by reducing smooth ...
Baker, A.H. +10 more
core +1 more source
Optimization of stent designs regarding the thrombosis risk using computational fluid dynamics
Current Directions in Biomedical Engineering, 2018 In-stent thrombosis is a major complication of stent implantations. Unlike pathological occurrences as in-stent restenosis for instance, thrombosis represents an acute event associated with high mortality rates.
Wüstenhagen Carolin +6 more
doaj +1 more source
Circulation, 2003 The concept of stenting—intravascular mechanical support by transluminally placed endoprostheses—was first proposed by Charles Dotter >30 years ago.1 As an intrinsic property of the metallic endoprostheses, early thrombotic occlusion of freshly deployed stents has been a concern since their introduction to human coronary circulation in 1986.2 The ...
Yasuhiro Honda, Peter J. Fitzgerald
openaire +1 more source
Stent thrombosis and drug-eluting stents [PDF]
Journal of Cardiology, 2011 Coronary stents have been used for the treatment of patients with coronary artery disease (CAD), and significantly improved procedural safety and are associated with a lower rate of restenosis compared with balloon angioplasty alone. Drug-eluting stents (DES) have been dominant for the treatment of CAD with efficacy in significantly reducing both ...
Takayama, Tadateru +2 more
openaire +2 more sources
Single versus two-stent strategies for coronary bifurcation lesions: a systematic review and meta-analysis of randomized trials with long-term follow-up [PDF]
, 2018 Background: The majority of coronary bifurcation lesions are treated with a provisional single‐stent strategy rather than an up‐front 2‐stent strategy.
Berry, Colin +8 more
core +1 more source
Subacute Stent Thrombosis in Intracranial Stenting [PDF]
Stroke, 2009 Background and Purpose— We sought to determine the safety of intracranial stenting with respect to subacute stent thrombosis in patients being treated with standardized antiplatelet therapy. Methods— We retrospectively ...
Christian H, Riedel +4 more
openaire +2 more sources
Informatics in Medicine Unlocked, 2021 Background: Conventional statistical methods used in clinical trials lack the ability to predict patient specific risk and very often do not consider the effects of time varying interventions.
Nadira Hamid +11 more
doaj +1 more source
A polymer coated cicaprost-eluting stent increases neointima formation and impairs vessel function in the rabbit iliac artery [PDF]
, 2016 Drug-eluting stents have been successful in reducing in-stent restenosis but are not suitable for all lesion types and have been implicated in causing late stent thrombosis due to incomplete regeneration of the endothelial cell layer.
Jones, Robert L. +4 more
core +2 more sources